Home Cart 0 Sign in  

[ CAS No. 321921-71-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 321921-71-5
Chemical Structure| 321921-71-5
Structure of 321921-71-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 321921-71-5 ]

Related Doc. of [ 321921-71-5 ]

Alternatived Products of [ 321921-71-5 ]

Product Details of [ 321921-71-5 ]

CAS No. :321921-71-5 MDL No. :MFCD05861606
Formula : C24H39P Boiling Point : -
Linear Structure Formula :- InChI Key :HTJWUNNIRKDDIV-UHFFFAOYSA-N
M.W : 358.54 Pubchem ID :11371790
Synonyms :

Calculated chemistry of [ 321921-71-5 ]

Physicochemical Properties

Num. heavy atoms : 25
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 5
Num. H-bond acceptors : 0.0
Num. H-bond donors : 0.0
Molar Refractivity : 112.85
TPSA : 13.59 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -3.85 cm/s

Lipophilicity

Log Po/w (iLOGP) : 4.47
Log Po/w (XLOGP3) : 6.53
Log Po/w (WLOGP) : 7.21
Log Po/w (MLOGP) : 6.94
Log Po/w (SILICOS-IT) : 6.8
Consensus Log Po/w : 6.39

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 0.0
Egan : 1.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.85
Solubility : 0.00051 mg/ml ; 0.00000142 mol/l
Class : Moderately soluble
Log S (Ali) : -6.61
Solubility : 0.0000875 mg/ml ; 0.000000244 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -5.68
Solubility : 0.000753 mg/ml ; 0.0000021 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 7.65

Safety of [ 321921-71-5 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P261-P264-P270-P271-P280-P301+P310+P330-P302+P352+P312-P304+P340+P311-P305+P351+P338-P332+P313-P337+P313-P403+P233-P405-P501 UN#:2811
Hazard Statements:H301+H311+H331-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 321921-71-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 321921-71-5 ]
  • Downstream synthetic route of [ 321921-71-5 ]

[ 321921-71-5 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 157282-19-4 ]
  • [ 321921-71-5 ]
Reference: [1] Patent: US2004/68131, 2004, A1,
[2] Patent: US2004/68131, 2004, A1,
  • 2
  • [ 109-65-9 ]
  • [ 131211-27-3 ]
  • [ 321921-71-5 ]
YieldReaction ConditionsOperation in experiment
13 mmol, 85% With n-butyllithium In toluene 4.6 g (15 mmol) of di(1-adamantyl)phosphine were placed in 50 ml of di-n-butyl ether, and 20 ml of a 2.5 M solution of n-BuLi in toluene (50 mmol) were added.
The mixture was refluxed for 1 h and cooled and 4.1 g (30 mmol) of 1-butyl bromide were added dropwise.
The mixture was refluxed for 30 min, cooled and washed with saturated ammonium chloride solution (3*), the organic phase was separated off and dried over sodium sulfate and the solvent was distilled off under reduced pressure.
Yield: 4.6 g (13 mmol, 85percent) of di(1-adamantyl)-n-butylphosphine.
The product can be recrystallized from di-n-butyl ether (m.p.: 102° C.).
31P{1H} NMR (162.0 MHz, C6D6, 297 K): δ=24.6
Reference: [1] Patent: US2004/68131, 2004, A1,
  • 3
  • [ 109-69-3 ]
  • [ 131211-27-3 ]
  • [ 321921-71-5 ]
YieldReaction ConditionsOperation in experiment
13 mmol, 85% With n-butyllithium In toluene 4.6 g (15 mmol) of di(1-adamantyl)phosphine were placed in 50 ml of di-n-butyl ether, and 20 ml of a 2.5 M solution of n-BuLi in toluene (50 mmol) were added.
The mixture was refluxed for 1 h and cooled and 2.8 g (30 mmol) of 1-butyl chloride were added dropwise.
The mixture was refluxed for 30 min, cooled and washed with saturated ammonium chloride solution (3*), the organic phase was separated off and dried over sodium sulfate and the solvent was distilled off under reduced pressure.
The product was purified by bulb tube distillation under fine vacuum. Yield: 4.6 g (13 mmol, 85percent) of di(1-adamantyl)-n-butylphosphine.
Reference: [1] Patent: US2004/68131, 2004, A1,
  • 4
  • [ 542-69-8 ]
  • [ 131266-79-0 ]
  • [ 321921-71-5 ]
Reference: [1] Journal of the American Chemical Society, 2012, vol. 134, # 23, p. 9727 - 9732
  • 5
  • [ 542-69-8 ]
  • [ 131211-27-3 ]
  • [ 321921-71-5 ]
Reference: [1] Synthesis, 2004, # 6, p. 935 - 941
  • 6
  • [ 109-72-8 ]
  • [ 157282-19-4 ]
  • [ 321921-71-5 ]
Reference: [1] Synlett, 2000, # 11, p. 1589 - 1592
  • 7
  • [ 847616-85-7 ]
  • [ 321921-71-5 ]
  • [ 1375477-29-4 ]
Reference: [1] Journal of the American Chemical Society, 2012, vol. 134, # 40, p. 16856 - 16868,13
[2] Journal of the American Chemical Society, 2012, vol. 134, # 40, p. 16856 - 16868
Same Skeleton Products
Historical Records